Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP versus standard treatment for grafted full-thickness burn wounds
NL-OMON35701Phase 4Active, not recruiting
- Sponsor
- Rode Kruis Ziekenhuis
- Start
- May 2010
- Modality
- Adoptive Cell Transfer → Cell Therapies
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of autologous platelet-rich plasma in burn injury (2 arms), sponsored by Rode Kruis Ziekenhuis. Primary endpoint: Time to complete healing. Started May 2010; status: active, not recruiting.
02
Drugs
autologous platelet-rich plasma
03
Conditions
burn injury
Beyond the preview
Go deeper on NL-OMON35701.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON35701.